HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Luiz Ricardo Goulart Selected Research

bothropstoxin II

1/2022A New Approach to Inhibiting Triple-Negative Breast Cancer: In Vitro, Ex Vivo and In Vivo Antiangiogenic Effect of BthTx-II, a PLA2-Asp-49 from Bothrops jararacussu Venom.
8/2019Antitumor and antimetastatic effects of PLA2-BthTX-II from Bothrops jararacussu venom on human breast cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Luiz Ricardo Goulart Research Topics

Disease

26Neoplasms (Cancer)
01/2022 - 12/2007
17Leprosy (Hansen's Disease)
05/2022 - 12/2004
11Breast Neoplasms (Breast Cancer)
06/2022 - 12/2015
11Infections
01/2020 - 10/2006
8Visceral Leishmaniasis (Kala Azar)
11/2021 - 01/2014
6Prostatic Neoplasms (Prostate Cancer)
12/2020 - 12/2007
6Leishmaniasis
04/2019 - 07/2015
5Inflammation (Inflammations)
04/2022 - 01/2019
5Triple Negative Breast Neoplasms
01/2022 - 01/2018
4Strongyloidiasis
03/2021 - 01/2014
4Neoplasm Metastasis (Metastasis)
01/2021 - 01/2016
4Hyperglycemia
10/2020 - 04/2011
4Diabetes Mellitus
10/2020 - 12/2011
3Carcinogenesis
11/2021 - 01/2010
3Parasitic Diseases (Parasitic Disease)
03/2021 - 11/2013
3Neurocysticercosis
05/2019 - 04/2010
2Experimental Arthritis
01/2022 - 06/2015
2Rheumatoid Arthritis
01/2022 - 06/2015
2HIV Infections (HIV Infection)
11/2021 - 11/2018
2Disease Progression
02/2021 - 11/2017
2COVID-19
01/2021 - 01/2020
2Adenocarcinoma
12/2020 - 06/2010
2Squamous Cell Carcinoma of Head and Neck
12/2019 - 01/2010
2Asymptomatic Infections
12/2017 - 07/2008
2Communicable Diseases (Infectious Diseases)
01/2016 - 08/2007
2Coronary Artery Disease (Coronary Atherosclerosis)
05/2005 - 11/2004
2Myocardial Infarction
05/2005 - 11/2004
1Breast Diseases (Breast Disease)
06/2022
1Virus Diseases (Viral Diseases)
04/2022
1Mitochondrial Diseases (Mitochondrial Disease)
01/2022
1Lung Neoplasms (Lung Cancer)
01/2022
1Wounds and Injuries (Trauma)
12/2021
1Coinfection
11/2021
1Bronchopulmonary Dysplasia
05/2021

Drug/Important Bio-Agent (IBA)

15AntigensIBA
11/2021 - 02/2009
14Peptides (Polypeptides)IBA
06/2022 - 04/2010
12Biomarkers (Surrogate Marker)IBA
04/2022 - 12/2007
12Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2010
12VaccinesIBA
10/2020 - 07/2008
9AntibodiesIBA
01/2020 - 04/2010
7Annexin A1IBA
01/2022 - 01/2010
7DNA (Deoxyribonucleic Acid)IBA
12/2021 - 06/2005
7CytokinesIBA
12/2021 - 12/2007
6Biological ProductsIBA
12/2021 - 01/2016
5VenomsIBA
01/2022 - 01/2016
5EpitopesIBA
11/2021 - 01/2014
4EnzymesIBA
11/2021 - 05/2015
4Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
05/2021 - 09/2015
4Antigen-Antibody Complex (Immune Complex)IBA
03/2021 - 05/2015
4GlycolipidsIBA
01/2020 - 11/2015
4Glucose (Dextrose)FDA LinkGeneric
01/2020 - 12/2011
4Immunoglobulin G (IgG)IBA
01/2019 - 04/2010
3AntioxidantsIBA
01/2022 - 01/2013
3MicroRNAs (MicroRNA)IBA
12/2020 - 01/2018
3Calcitriol Receptors (Calcitriol Receptor)IBA
03/2018 - 10/2006
3LigandsIBA
01/2016 - 04/2010
3LeprominIBA
11/2015 - 12/2004
3Myosins (Myosin)IBA
01/2013 - 04/2011
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 01/2020
2bothropstoxin IIIBA
01/2022 - 08/2019
2Pharmaceutical PreparationsIBA
01/2022 - 06/2017
2AcidsIBA
12/2021 - 04/2016
2Hypoglycemic Agents (Hypoglycemics)IBA
10/2020 - 05/2014
2Immunoglobulin M (IgM)IBA
01/2020 - 01/2018
2RutheniumIBA
01/2020 - 06/2010
2ProteomeIBA
12/2019 - 01/2014
2Recombinant ProteinsIBA
04/2019 - 07/2016
2Snake Venoms (Snake Venom)IBA
01/2019 - 04/2017
2Interleukin-10 (Interleukin 10)IBA
01/2019 - 01/2019
2Interferon-gamma (Interferon, gamma)IBA
01/2019 - 09/2015
2Interleukin-12 (IL 12)IBA
01/2019 - 09/2015
2BnSP-6IBA
01/2019 - 01/2016
2BCG VaccineFDA Link
01/2018 - 11/2015
2ImmunosorbentsIBA
05/2015 - 05/2015
2Messenger RNA (mRNA)IBA
01/2010 - 12/2007
2Transforming Growth Factor beta1 (TGF beta 1)IBA
02/2009 - 12/2007
1propionic acid (potassium propionate)IBA
06/2022
1Ketoconazole (Nizoral)FDA LinkGeneric
01/2022
1cadmium selenideIBA
01/2022
1Antineoplastic Agents (Antineoplastics)IBA
01/2022
1matrigelIBA
01/2022
1Formyl Peptide Receptors (Formyl Peptide Receptor)IBA
01/2022
1Interleukin-6 (Interleukin 6)IBA
01/2022
1CopperIBA
12/2021
1MicronutrientsIBA
12/2021
1PhenanthrolinesIBA
12/2021
1HydrazinesIBA
12/2021
1LysophospholipidsIBA
11/2021
1Phospholipids (Phosphatides)FDA LinkGeneric
11/2021
1Phospholipases A2 (Phospholipase A2)IBA
11/2021
1Nonesterified Fatty Acids (NEFA)IBA
11/2021
1Arachidonic Acid (Vitamin F)IBA
11/2021
1Oxygen (Dioxygen)IBA
05/2021

Therapy/Procedure

8Therapeutics
05/2022 - 01/2014
5Drug Therapy (Chemotherapy)
12/2021 - 07/2008
3Precision Medicine
04/2019 - 07/2015
2Quantum Dots (Quantum Dot)
01/2022 - 01/2016
2Immunotherapy
12/2015 - 07/2015
1Intradermal Injections
12/2021
1Mechanical Ventilators (Ventilator)
05/2021